Skip to main content

University of Maryland Baltimore Lab Develops Molecular Rapid COVID Test

Scientists at University of Maryland, Baltimore have developed a molecular rapid COVID-19 test that is designed to be just as effective as the currently available variety of tests that are sent to a lab for processing. New York-based RNA Disease Diagnostics recently completed a licensing deal for this technology with UM Ventures, and will pursue emergency use authorization from the U.S. Food and Drug Administration.


Read More